Skip to content

Clinical trials

Terminated Phase 2 Lymphoma, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Phase: Phase 2 Status: Terminated Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20065
20072
20081
20091
20101
20111
20132
20141
20152
20163
20172
20201
20211
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seagen Inc.3
Fred Hutchinson Cancer Center2
Academic and Community Cancer Research United1
Astellas Pharma Inc1
CARGO Therapeutics1
Cedars-Sinai Medical Center1
Duke University1
Emory University1
Fondazione Italiana Linfomi - ETS1
French Innovative Leukemia Organisation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell30
Lymphoma, Large B-Cell, Diffuse13
Lymphoma, Non-Hodgkin12
Lymphoma11
Lymphoma, Follicular6
Leukemia, Lymphocytic, Chronic, B-Cell5
Neoplasms5
Hematologic Diseases4
Lymphatic Diseases4
Burkitt Lymphoma3

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.